Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
There's a lot of growth on the way, and soon.
1 Biotech Stock Down 62% to Buy and Hold
It's an excellent opportunity to buy shares of what could become a biotech giant on the dip.
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
An investment in these players today could score a big win down the road.
Looking for Stock Bargains With Room to Run? Try This.
Investing tips from Bill Mann, The Motley Fool's director of small-cap research.
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?
Is the potential upside for CRISPR Therapeutics too massive to ignore?
3 Monster Biotech Stocks to Buy Before 2025
These companies are nearly in the sweet spot of risk versus reward in biotech.
How major US stock indexes fared Wednesday, 8/28/2024
Losses for several big technology companies pulled the stock market lower
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
The companies are chasing major innovations.
Got the Market Sell-Off Blues? Do These 3 Things Right Now
You aren't powerless in the face of what the market throws at you.